BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 27280515)

  • 1. Surgical Outcomes for Mastectomy Patients Receiving Neoadjuvant Chemotherapy: A Propensity-Matched Analysis.
    Bowen ME; Mone MC; Buys SS; Sheng X; Nelson EW
    Ann Surg; 2017 Mar; 265(3):448-456. PubMed ID: 27280515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in Patients Receiving Neoadjuvant Chemotherapy Undergoing Immediate Breast Reconstruction: Effect of Timing, Postoperative Complications, and Delay to Radiation Therapy.
    Teotia SS; Venutolo C; Haddock NT
    Plast Reconstr Surg; 2019 Nov; 144(5):732e-742e. PubMed ID: 31688746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
    Monrigal E; Dauplat J; Gimbergues P; Le Bouedec G; Peyronie M; Achard JL; Chollet P; Mouret-Reynier MA; Nabholtz JM; Pomel C
    Eur J Surg Oncol; 2011 Oct; 37(10):864-70. PubMed ID: 21843920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy.
    Nogi H; Ogiya A; Ishitobi M; Yamauchi C; Mori H; Shimo A; Narui K; Nagura N; Seki H; Sasada S; Sakurai T; Shien T;
    Breast Cancer; 2024 May; 31(3):507-518. PubMed ID: 38573438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma.
    Paillocher N; Florczak AS; Richard M; Classe JM; Oger AS; Raro P; Wernert R; Lorimier G
    Eur J Surg Oncol; 2016 Jul; 42(7):949-55. PubMed ID: 27134148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
    Vila J; Teshome M; Tucker SL; Woodward WA; Chavez-MacGregor M; Hunt KK; Mittendorf EA
    Ann Surg; 2017 Mar; 265(3):574-580. PubMed ID: 27735826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer.
    Donker M; Hage JJ; Woerdeman LA; Rutgers EJ; Sonke GS; Vrancken Peeters MJ
    Eur J Surg Oncol; 2012 Jan; 38(1):25-30. PubMed ID: 21963981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide trends in mastectomy for early-stage breast cancer.
    Kummerow KL; Du L; Penson DF; Shyr Y; Hooks MA
    JAMA Surg; 2015 Jan; 150(1):9-16. PubMed ID: 25408966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction.
    Warren Peled A; Itakura K; Foster RD; Hamolsky D; Tanaka J; Ewing C; Alvarado M; Esserman LJ; Hwang ES
    Arch Surg; 2010 Sep; 145(9):880-5. PubMed ID: 20855759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: A safe option?
    Allué Cabañuz M; Arribas Del Amo MD; Gil Romea I; Val-Carreres Rivera MP; Sousa Domínguez R; Güemes Sánchez AT
    Cir Esp (Engl Ed); 2019 Dec; 97(10):575-581. PubMed ID: 31530386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of BMI on modality-specific outcomes in immediate breast reconstruction (IBR)--a propensity-matched analysis using the 2005-2011 ACS-NSQIP datasets.
    Fischer JP; Wes AM; Kanchwala S; Kovach SJ
    J Plast Surg Hand Surg; 2014 Oct; 48(5):297-304. PubMed ID: 24443774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of skin-sparing mastectomy with immediate reconstruction in patients with Stage III breast cancer treated with neoadjuvant chemotherapy and postmastectomy radiation.
    Prabhu R; Godette K; Carlson G; Losken A; Gabram S; Fasola C; O'Regan R; Zelnak A; Torres M
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e587-93. PubMed ID: 22197232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing postoperative outcomes following neoadjuvant chemotherapy and mastectomy with immediate reconstruction: A national analysis.
    Thawanyarat K; Johnstone T; Rowley M; Navarro Y; Hinson C; Nazerali RS
    J Surg Oncol; 2023 Apr; 127(5):768-775. PubMed ID: 36602535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of neoadjuvant chemotherapy on wound complications after breast surgery.
    Decker MR; Greenblatt DY; Havlena J; Wilke LG; Greenberg CC; Neuman HB
    Surgery; 2012 Sep; 152(3):382-8. PubMed ID: 22739071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapy.
    Wengler CA; Valente SA; Al-Hilli Z; Woody NM; Muntean JH; Abraham J; Tendulkar RD; Djohan R; O'Rourke C; Crowe JP; Grobmyer SR
    J Surg Oncol; 2017 Dec; 116(7):797-802. PubMed ID: 28699269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?
    Katz A
    J Clin Oncol; 2005 Sep; 23(27):6796; author reply 6796-7. PubMed ID: 16170189
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of neoadjuvant and adjuvant chemotherapy on the surgical outcomes of breast reconstruction.
    Oh E; Chim H; Soltanian HT
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):e267-80. PubMed ID: 22633392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.